Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 8/20 | 0.50 |
| ▸ | CA1 | P00915 | 6/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | NT5E | P21589 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 3/20 | 0.40 |
| ▸ | CA4 | P22748 | 3/20 | 0.40 |
| ▸ | CA6 | P23280 | 3/20 | 0.40 |
| ▸ | CA5A | P35218 | 3/20 | 0.40 |
| ▸ | CA7 | P43166 | 3/20 | 0.40 |
| ▸ | CA9 | Q16790 | 3/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.40 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL27785607 | 0.98 | LMNA (0.50) | LMNACA2CA1TSHRALDH1A1 | |
| SCHEMBL14830748 | 0.98 | LMNA (0.50) | LMNACA2CA1TSHRALDH1A1 | |
| Hydrochloric Acid SCHEMBL11584379 | 0.98 | LMNA (0.50) | LMNACA2CA1TSHRALDH1A1 | |
| SCHEMBL11335180 | 0.94 | LMNA (0.46) | LMNACA2CA1TSHRALDH1A1 | |
| SCHEMBL17212140 | 0.82 | LMNA (0.48) | LMNACA2CA1TSHRALDH1A1 | |
| SCHEMBL9619529 | 0.80 | LMNA (0.56) | LMNACA2CA1TSHRALDH1A1 | |
| SCHEMBL11583429 | 0.80 | LMNA (0.56) | LMNACA2CA1TSHRALDH1A1 | |
| SCHEMBL3539406 | 0.80 | CYP3A4 (0.52) | LMNACA2CA1TSHRALDH1A1 | |
| SCHEMBL150334 | 0.79 | LMNA (0.77) | LMNACA2CA1TSHRALDH1A1 | |
| SCHEMBL755114 | 0.79 | CA2 (0.47) | LMNACA2CA1TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109180539-A | Pipelineization prepares the method and device of the chloro- 4- toluenesulfonic acid of 2- nitro -5- | 浙江工业大学 | 2019-01-11 | — | — | CN | claimed |
| CN-108367529-A | Light flame-retardant thermoplastic structure | 施内勒公司 | 2018-08-03 | — | — | CN | claimed |
| CN-105541667-B | The method that continuous conduit metaplasia produces CLT acid itrated compound | 浙江秦燕科技股份有限公司 | 2018-04-20 | — | — | CN | claimed |
| JP-60045246-A | — | — | None | — | — | JP | disclosed |
| CN-119060221-A | Sulfonic acid functionalized polymer, ion exchange membrane and application thereof | 佛山绿动氢能科技有限公司 | 2024-12-03 | — | — | CN | disclosed |
| CN-113797842-B | Hydrocarbyl aryl anionic nonionic surfactant and preparation method thereof | 中国石油化工股份有限公司 | 2023-08-29 | — | — | CN | disclosed |
| US-20220220151-A1 | METHOD FOR PREPARING PEPTIDES | SULFOTOOLS GMBH (DE) | 2022-07-14 | — | — | US | disclosed |
| US-11319340-B2 | Method for preparing peptides | SULFOTOOLS GMBH (DE) | 2022-05-03 | — | — | US | disclosed |
| CN-109689051-B | Use of inhibitors of mitochondrial activity for the treatment of acute myeloid leukemia with poor prognosis | 蒙特利尔大学 | 2022-03-29 | — | — | CN | disclosed |
| CN-111234818-B | Method for synthesizing surface functional group modified carbon quantum dots and application of carbon quantum dots in nano oil displacement | 西南石油大学 | 2022-03-18 | — | — | CN | disclosed |
| CN-113797842-A | Alkyl aryl anionic nonionic surfactant and preparation method thereof | 中国石油化工股份有限公司 | 2021-12-17 | — | — | CN | disclosed |
| US-5075488-A | Fungicides | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1991-12-24 | — | — | US | disclosed |
| EP-0128006-B1 | A SOIL-DISEASE-CONTROLLING AGENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1991-09-18 | — | — | EP | disclosed |
| US-4709052-A | FUNGICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1987-11-24 | — | — | US | disclosed |
| JP-S6045246-A | FORMATION OF RESIST PATTERN | OKI ELECTRIC IND CO LTD | 1985-03-11 | — | — | JP | disclosed |
| EP-0128006-A2 | A soil-disease-controlling agent | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-12-12 | — | — | EP | disclosed |
| US-4418015-A | Phthalocyanine reactive dyestuffs | BAYER AKTIENGESELLSCHAFT (DE) | 1983-11-29 | — | — | US | disclosed |
| EP-0053320-A2 | Process for the preparation of phthalocyanin compounds | BAYER AG (DE) | 1982-06-09 | — | — | EP | disclosed |
| EP-0047863-A2 | Reactive phthalocyanine hyes, process for their preparation and their use in dyeing materials containing hydroxyle groups and/or nitrogen | BAYER AG (DE) | 1982-03-24 | — | — | EP | disclosed |
| JP-S0645246-A | — | — | 0001-01-01 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11319340-B2 | Method for preparing peptides | VIP, DNPEP, PEPD | LMNA 2611/4885CA2 466/4885CA1 156/4885 |
| US-20220220151-A1 | METHOD FOR PREPARING PEPTIDES | VIP, DNPEP, PEPD | LMNA 1913/4885CA2 1059/4885CA1 223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.